The efficacy of prophylactic ondansetron , droperidol , perphenazine , and metoclopramide in the prevention of nausea and vomiting <font color="blue">after_1</font> <font color="blue">major_1</font> <font color="blue">gynecologic_1</font> <font color="blue">surgery_1</font> <font color="blue">._1</font> 
<br>
<br> The prophylactic antiemetic efficacy of intravenous ( i.v . ) ondansetron , droperidol , perphenazine , and metoclopramide was evaluated in a prospective , <font color="blue">double_1</font> <font color="blue">-_1</font> <font color="blue">blind_1</font> <font color="blue">study_1</font> <font color="blue">of_1</font> <font color="blue">360_6</font> <font color="blue">ASA_6</font> <font color="blue">physical_6</font> <font color="blue">status_6</font> <font color="blue">I_6</font> <font color="blue">-_6</font> <font color="blue">III_6</font> <font color="blue">patients_6</font> <font color="blue">undergoing_4</font> <font color="blue">total_4</font> <font color="blue">abdominal_4</font> <font color="blue">hysterectomy_4</font> <font color="blue">(_4</font> <font color="blue">TAH_4</font> <font color="blue">)_4</font> <font color="blue">._3</font> <font color="blue">Subjects_1</font> were randomized to receive i.v . , one of ondansetron 4 mg , droperidol 1.25 mg , perphenazine 5 mg , metoclopramide 10 mg , or placebo prior to induction of anesthesia . Hypotension immediately after administration of metoclopramide was observed in two patients and four patients given ondansetron developed profound systolic hypotension at induction of anesthesia . <font color="blue">Twenty_1</font> <font color="blue">-_1</font> <font color="blue">two_1</font> <font color="blue">percent_1</font> <font color="blue">of_1</font> <font color="blue">patients_2</font> receiving droperidol became sedated . Postoperatively , <font color="blue">patients_1</font> developing severe nausea , retching , or vomiting , defined as severe emetic sequelae ( SES ) , were deemed to have failed antiemetic prophylaxis and received antiemetic rescue . A significantly larger number <font color="blue">of_1</font> <font color="blue">patients_1</font> who received i.v . ondansetron ( 63% ) , droperidol ( 76% ) , and perphenazine ( 70% ) were free of SES when compared to placebo ( 43% ) ; P < 0.05 . Metoclopramide was ineffective . Although ondansetron , droperidol , and perphenazine were effective in providing antiemetic prophylaxis , only i.v . perphenazine was free of side effects . Hence , we conclude that perphenazine is the best choice for antiemetic prophylaxis after TAH .